Key statistics
As of last trade XOMA Royalty Corp (X0M1:MUN) traded at 28.40, -4.70% below its 52-week high of 29.80, set on Nov 07, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 28.40 |
---|---|
High | 28.40 |
Low | 28.40 |
Bid | 28.80 |
Offer | 29.60 |
Previous close | 28.00 |
Average volume | 0.00 |
---|---|
Shares outstanding | 11.70m |
Free float | 11.57m |
P/E (TTM) | -- |
Market cap | 362.49m USD |
EPS (TTM) | -2.22 USD |
Data delayed at least 15 minutes, as of Nov 11 2024 07:00 GMT.
More ▼
- XOMA Royalty Reports Third Quarter 2024 Financial Results and Highlights Recent Activities
- XOMA Royalty Significantly Expands its Royalty and Milestone Portfolio with the Addition of Over 60 Early-Stage Programs from Twist Bioscience
- Zevra’s MIPLYFFA™ (arimoclomol) Receives Approval from U.S. Food and Drug Administration for Use in Patients with Niemann-Pick Disease Type C (NPC)
- XOMA Royalty Declares Quarterly Preferred Stock Dividends
- XOMA Royalty to Present at Upcoming Investor Conferences in September
- XOMA Royalty Reports Second Quarter 2024 Financial Results and Highlights Recent Activities
- XOMA Declares Quarterly Preferred Stock Dividends
- XOMA Receives $8.1 Million Milestone Related to Day One Biopharmaceuticals’ Sale of its Priority Review Voucher
- XOMA to Present at H.C. Wainwright 2nd Annual Bioconnect Investor Conference at NASDAQ
- XOMA Reports First Quarter 2024 Financial Results and Highlights Recent Activities
More ▼